Converge Bio

Converge Bio provides a generative AI platform for drug discovery and development, targeting biotech and pharmaceutical companies. They utilize proprietary foundation models trained on biological data to optimize antibody design and protein manufacturing. The company differentiates itself through a closed-loop, experimentally validated approach that combines bio-LLMs with wet-lab validation.